Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
BMC
2023-05-01
|
| Sraith: | Journal of Translational Medicine |
| Rochtain ar líne: | https://doi.org/10.1186/s12967-023-04186-4 |